FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Bound Tree Medical curaplex Epi Safe Administration and Recall

curaplex Epi Safe Administration and Training Kits # 8600-01100

Bound Tree Medical, LLC · Dallas, TX

Risk level
Class II
Reported by FDA
Jan 23, 2019
Recall ID
D-0371-2019
Check your lot numberHow we source this data

Summary

Bound Tree Medical recalled curaplex Epi Safe Administration and starting Nov 1, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0371-2019 on Jan 23, 2019. Reason: Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date of January 2020. In addition, device component (syringe) may lack 510(k) clearance. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date of January 2020. In addition, device component (syringe) may lack 510(k) clearance.

Product description

curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administration Kit (8600-01101) and 1 Epi Safe Training Kit (8600-01102), Rx Only. Distributed by Sarnova HC, LLC's family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Producs, Inc. & Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd, Dublin, OH 43016

Lot numbers, UPCs & expiration codes

Lot # ASM0018348, EXP 12-31-2018

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0371-2019
Classification
Class II
Status
Terminated
Recall initiated
Nov 1, 2018
FDA report date
Jan 23, 2019
Quantity
84 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Bound Tree Medical, LLC

Original FDA data

Every field from FDA enforcement report D-0371-2019, exactly as published.

Show all FDA fields
City
Dallas
State
TX
Status
Terminated
Country
United States
Event ID
81504
Address
1420 Lakeside Parkway
Code information
Lot # ASM0018348, EXP 12-31-2018
Postal code
75208
Report date
Jan 23, 2019
Product type
Drugs
Recall number
D-0371-2019
Classification
Class II
Recalling firm
Bound Tree Medical, LLC
Product quantity
84 kits
Termination date
Jan 24, 2020
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date of January 2020. In addition, device component (syringe) may lack 510(k) clearance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administration Kit (8600-01101) and 1 Epi Safe Training Kit (8600-01102), Rx Only. Distributed by Sarnova HC, LLC's family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Producs, Inc. & Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd, Dublin, OH 43016
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Nov 1, 2018
Initial firm notification
Letter
Center classification date
Jan 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0371-2019, published Jan 23, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls